Octenidine Hydrochloride(Carefusion)

盐酸奥替尼啶(Carefusion)

Report date: 2022/11/25 17:01:15

Base Information

Drug NameOctenidine Hydrochloride(Carefusion)
Drug Alias NameBDIP-0001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytotoxicity
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCarefusion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC. R. Bard
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A